S0307 Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

National Cancer Institute (NCI)

North Central Cancer Treatment Group

Eastern Cooperative Oncology Group

NSABP Foundation Inc

Cancer and Leukemia Group B

NCIC Clinical Trials Group

Information provided by (Responsible Party):

Southwest Oncology Group

ClinicalTrials.gov Identifier:

NCT00127205

First received: August 3, 2005

Last updated: July 25, 2016

Last verified: July 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	May 2020
Estimated Primary Completion Date:	August 2016 (Final data collection date for primary outcome measure)